The University of Texas MD Anderson Cancer Center this week was awarded $7.5 million from the Cancer Prevention and Research Institute of Texas (CPRIT). The awards included $3.8 million for early translational, individual investigator and high-risk/high-impact research, and $3.7 million for core facility support.
Since its inception, CPRIT has awarded $1.89 billion in grants for cancer research, of which MD Anderson has received...
The 28th annual A Conversation With a Living Legend® in Dallas, Sept. 14 at the Hilton Anatole, honors architect, artist and engineer Santiago...
Cancer immunotherapies that block two different checkpoints on T cells launch immune attacks on cancer by expanding distinct types of T cell...
The University of Texas MD Anderson Cancer Center again has ranked No. 1 for cancer care by U.S. News & World Report’s annual “Best Hospitals” survey. Since the survey began in 1990, MD Anderson has been named one of the top two cancer hospitals, and it has ranked first 13 times in the last 16 years.
“To consistently be recognized for the quality and compassionate cancer care we provide patients who come to MD Anderson seeking...
For patients with advanced, inoperable stage 3 lung cancer, concurrent chemotherapy and the specialized radiation treatment, proton therapy...
Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down...
The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center...
Joint Statement from Dr. Joseph M. Herman, Clinical Research Director, Department of Radiation Oncology, The University of Texas MD Anderson...
The University of Texas MD Anderson Cancer Center today announced a new leadership structure designed to enhance teamwork and collaborative...
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to predict who will respond to standard...